{
  "nctId": "NCT02991430",
  "briefTitle": "A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache",
  "officialTitle": "A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache",
  "protocolDocument": {
    "nctId": "NCT02991430",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2016-08-09",
    "uploadDate": "2019-04-26T07:23",
    "size": 8705651,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02991430/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "TRIPLE",
  "enrollmentInfo": {
    "enrollmentCount": 45,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2017-06-30",
    "completionDate": "2018-05-11",
    "primaryCompletionDate": "2018-05-11",
    "firstSubmitDate": "2016-12-04",
    "firstPostDate": "2016-12-13"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* diagnosed with episodic migraine at least 6 months before study\n* at least 3 consecutive months of stable migraine headaches before study\n* at least 4-14 headache days per month, of which 4-14 may be migraines\n* must not have failed on more than 2 classes of migraine preventatives\n\nExclusion Criteria:\n\n* previous use of the experimental device\n* pregnant\n* using more than 1 concurrent migraine preventive\n* history of cardiovascular disease\n* work night shifts\n* diagnosed with vestibular migraine\n* menstrual migraines exclusively\n* diagnosed with post-traumatic migraine\n* have a history of unstable mood or anxiety disorder\n* use a hearing aid\n* have a cochlear implant\n* have chronic tinnitus\n* have temporomandibular joint disease\n* diagnosed with traumatic brain injury\n* diagnosed with neurological disease other than headaches\n* diagnosed vestibular and/or balance dysfunction\n* history of abusing alcohol or other drugs\n* are experiencing medication overuse headaches\n* have had eye surgery in the previous 3 months\n* have had ear surgery in the previous 6 months\n* have active ear infections or a perforated tympanic membrane\n* have participated in another clinical trial in the last 30 days\n* are currently participating in another clinical trial\n* using Botulinum toxin-based treatments for migraines or cosmetic reasons\n* taking anti-emetics more than 2 times per week (consistently)",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "65 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in Migraine Headache Days (MHD)",
        "description": "comparison of MHD recorded in baseline month versus 3rd month of treatment",
        "timeFrame": "1 month of baseline recordation followed by 84 days of device use"
      }
    ],
    "secondary": [
      {
        "measure": "Normalized Reduction in Migraine Headache Days",
        "description": "comparison of MHD recorded in baseline month versus 3rd month of treatment: percentages, active versus placebo",
        "timeFrame": "1 month of baseline recordation followed by 84 days of device use"
      },
      {
        "measure": "Change in Medication Usage",
        "description": "reduction in acute, prescribed medications in month 3 of treatment versus baseline month",
        "timeFrame": "1 month of baseline recordation followed by 84 days of device use"
      },
      {
        "measure": "Change in Headache Pain",
        "description": "reduction in subject perceived headache pain scores in month 3 of treatment versus baseline month",
        "timeFrame": "1 month of baseline recordation followed by 84 days of device use"
      },
      {
        "measure": "Change in Quality of Life",
        "description": "comparison of HIT-6 (headache impact test) scores between baseline month and treatment month 3",
        "timeFrame": "1 month of baseline recordation followed by 84 days of device use"
      },
      {
        "measure": "Change in Depression",
        "description": "comparison of BDI-II (Beck depression index) scores between baseline month and treatment month 3",
        "timeFrame": "1 month of baseline recordation followed by 84 days of device use"
      },
      {
        "measure": "Change in Anxiety",
        "description": "comparison of BAI (Beck anxiety index) scores between baseline month and treatment month 3",
        "timeFrame": "1 month of baseline recordation followed by 84 days of device use"
      },
      {
        "measure": "Change in Sleep Quality",
        "description": "comparison of Pittsburgh Sleep assessment scores between baseline month and treatment month 3",
        "timeFrame": "1 month of baseline recordation followed by 84 days of device use"
      },
      {
        "measure": "Additional Treatment Time",
        "description": "comparison of MHD recorded in baseline month versus 6th month of treatment",
        "timeFrame": "1 month of baseline recordation followed by 168 days of device use"
      },
      {
        "measure": "Sustained Reduction in Migraine Headache Days",
        "description": "comparison of MHD recorded in baseline month versus post-treatment months 7, 8 and 9",
        "timeFrame": "1 month of baseline recordation followed by 252 days of device use"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 9,
      "otherCount": 0,
      "totalCount": 10
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 84,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:53.263Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}